Loading...
Market
What will be Cardinal Health's Q1 FY25 revenue?
2
Resolution / Starting Odds
Below $60 billion • 25%
$60 billion to $62 billion • 25%
$62 billion to $64 billion • 25%
Above $64 billion • 25%
Cardinal Health's official Q1 FY25 earnings report
Story
Cardinal Health Surpasses Q4 Expectations, Raises FY25 Guidance; Stock Up 5%
Aug 14, 2024, 12:00 PM
Cardinal Health reported its fourth-quarter and fiscal year 2024 results, surpassing market expectations and subsequently raising its fiscal year 2025 guidance. The company announced a non-GAAP adjusted earnings per share (EPS) of $1.84, exceeding the estimated $1.73, marking a 29% increase year-over-year. Revenue for the quarter reached $59.9 billion, surpassing the forecasted $58.54 billion and reflecting a 12% year-over-year growth. Cardinal Health also reported a GAAP diluted EPS of $0.96. The fiscal year 2025 adjusted EPS guidance was raised to a range of $7.55 to $7.70, up from the previous estimate of at least $7.50. This optimistic outlook is driven by strong demand for branded and specialty medicines in its pharmaceuticals unit. The company's stock rose by 5%, and by 6.30% in pre-market trading, following the earnings announcement.
View original story
Similar markets
Below $16.85 billion • 25%
$16.85 billion to $17.00 billion • 25%
$17.00 billion to $17.45 billion • 25%
Above $17.45 billion • 25%
Less than $90 billion • 25%
$90 billion to $95 billion • 25%
$95 billion to $100 billion • 25%
More than $100 billion • 25%
Below $1.00 • 25%
$1.00 to $1.50 • 25%
Above $1.50 • 25%
Other • 25%
Below $13.65 billion • 25%
$13.65 billion to $13.74 billion • 25%
$13.75 billion to $13.85 billion • 25%
Above $13.85 billion • 25%
Below $21.5 billion • 33%
$21.5 billion - $22.5 billion • 34%
Above $22.5 billion • 33%
Below $640 million • 25%
$640 million to $655 million • 25%
$655 million to $670 million • 25%
Above $670 million • 25%
Below $14.5 billion • 25%
$14.5 billion to $14.6 billion • 25%
$14.6 billion to $14.7 billion • 25%
Above $14.7 billion • 25%
Less than $38 billion • 25%
$38 billion to $39 billion • 25%
$39 billion to $40 billion • 25%
More than $40 billion • 25%
Below $147 billion • 25%
$147 billion to $151 billion • 25%
Above $151 billion • 25%
Not disclosed • 25%
Below $1.00 • 25%
$1.00 to $1.10 • 25%
$1.11 to $1.20 • 25%
Above $1.20 • 25%
Above $100 billion • 25%
$95 billion to $100 billion • 25%
$90 billion to $95 billion • 25%
Below $90 billion • 25%